Industry Providers Related News

Dr. Una Ryan Joins Elemental Machines Board of Directors

June 15, 2017 09:00 AM Eastern Daylight Time CAMBRIDGE, Mass. & SAN FRANCISCO--(BUSINESS WIRE)--Elemental Machines today announced that the distinguished Dr. Una Ryan, OBE has joined its Board of Directors. Bringing more than 50 years of experience to this role, Ryan [...]

Twist Bioscience and the BioBricks Foundation Announce Partnership to Provide 10,000 Public-Benefit Genes to the Synthetic Biology Community

SAN FRANCISCO, Calif. – June 15, 2017 – Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, and the BioBricks Foundation today announced a groundbreaking agreement to provide 10,000 genes to the synthetic biology community. Under [...]

By | June 15th, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

Twist Bioscience and BioBricks Foundation Announce Unique Partnership

Twist Bioscience, a leader in the field of DNA synthesis, and BioBricks Foundation, a charity foundation for the advancement of biotechnology, announced today an agreement to provide 10,000 genes to the synthetic biology community. With this pioneering agreement, BioBricks will [...]

By | June 15th, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

Twist Bioscience Adds $27 Million to its 2017 Financing

Twist Bioscience, the rising star of DNA synthesis, has announced the completion of its most recent financing round with the addition of $27 million to the raise.  In combination with the $33 million in funding that Twist announced in March, [...]

By | June 15th, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

Integrated DNA Technologies Launches New Grant Program Aimed at Synthetic Biology Startups

Integrated DNA Technologies, the world’s largest manufacturer of nucleic acids, has announced the launch of a new grant program specifically aimed at supporting synthetic biology startups. The grant is dedicated to enabling research and development early stage companies by supplying [...]

By | June 5th, 2017|DNA Synthesis, Industry Providers, News|

ATUM and Horizon Discovery Announce Collaboration and Technology Cross-License to Simplify and Speed Bioproduction Cell Line Development

Newark, CA, and Cambridge, UK, June 1, 2017: ATUM (formerly DNA2.0, Inc.) and Horizon Discovery (LSE: HZD) (“Horizon”), the world leader in the application of gene editing technologies, today announced they have signed a cross-license agreement for Horizon’s CHO SOURCE [...]